Condition

Cardiac Amyloidosis

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting10
Common interventions17
Lead sponsors shown15
Advertisement

Clinical trials

17 shown
Liver and Coagulation Disorders in Cardiac Transthyretin AmyloidosisNCT07766135 · 2026-01-30
RECRUITING
US Benchmarking Clinical StudyNCT07215715 · 2025-09-16
RECRUITING
[18F]FT8 PET Imaging in Immunoglobulin Light Chain AmyloidosisNCT07232459 · 2025-07-21
RECRUITING
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart FailureNCT06427304 · 2024-07-01
RECRUITING
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) StudyNCT06096675 · 2024-01-22
RECRUITING
Pan-Amyloid PET/CT in Various Amyloid-Related DiseaseNCT07130565 · 2023-11-01
RECRUITING
Cardiac Amyloidosis Registry of University Hospital LeipzigNCT06129656 · 2023-05-01
RECRUITING
Cardiovascular Multimodality Imaging StudyNCT06610019 · 2023-05-01
RECRUITING
A Multi-center Cardiac PYP Scan Registry in TaiwanNCT05593679 · 2022-11-01
RECRUITING
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's DiseaseNCT07154394 · 2022-08-15
RECRUITING
AI-based Echocardiography for Detection of Cardiac AmyloidosisNCT07529860 · 2026-07-01
NOT_YET_RECRUITING
N-of-1 for Beta-Blockers in Cardiac AmyloidosisNCT05019027 · 2024-01-31
COMPLETED
Amyloidosis Incidence in High-Risk Cardiac Device PatientsNCT06186167 · 2024-01-29
UNKNOWN
Exercise Training and Rehabilitation In Cardiac AmyloidosisNCT06412432 · 2024-01-10
UNKNOWN
Cardiac Amyloidosis in HFpEF Tunisian PatientsNCT06201832 · 2023-07-01
COMPLETED
CMR T1 Mapping for Diagnosis of Cardiac AmyloidosisNCT04862273 · 2021-04-01
COMPLETED
Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid DepositsNCT03616496 · 2019-06-06
COMPLETED

Common interventions

Trial status mix

RECRUITING10
COMPLETED4
UNKNOWN2
NOT_YET_RECRUITING1

Phase mix

NA4
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.